A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold ResponseDuško Lainšček, Roman Jerala, Mateja Manček‐Keber et al.|Vaccines|2021Cited by 36
Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike proteinDuško Lainšček, Roman Jerala, Tina Fink et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 10
Hydroxychloroquine decouples reactogenicity from efficacy in mRNA and viral-vector gene deliveryDuško Lainšček, Roman Jerala, Špela Malenšek et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0